Welcome to the 6th European Multidisciplinary Meeting on Urological Cancers (EMUC) and the 3rd EAU Section of Urological Imaging (ESUI)
v
Welcome to the 6th European Multidisciplinary Meeting on Urological Cancers (EMUC) and the 3rd EAU Section of Urological Imaging (ESUI) We welcome ...
Welcome to the 6th European Multidisciplinary Meeting on Urological Cancers (EMUC) and the 3rd EAU Section of Urological Imaging (ESUI) We welcome all participants to the 6th European Multidisciplinary Meeting on Urological Cancers (EMUC) and the 3rd EAU Section of Urological Imaging (ESUI), an international meeting that highlights the gains and challenges in providing optimal treatment to onco-urology patients. With our goal to further examine the advances and prospects in onco-urology, we acknowledge the role of holding this event as an effective platform for experts to identify areas of collaboration and keep up with new developments. Thus, the EMUC has been organised annually since 2011, contributing to the wider efforts to integrate multidisciplinary care in the hospital setting. A multidisciplinary approach can only lead to a more refined understanding of urological malignancies, and the rapid changes in treatment strategies are best examined within the context of collaborative work. The EMUC also offers participants the opportunity to actively engage with cutting-edge science and for them to cast a critical eye on standard approaches in urology, medical oncology and radiology. This year two meetings will kick off EMUC’s main programme. The EAU Section of Urological Imaging (ESUI) and the EAU-ICUD Consensus meeting on Medical Treatment of Urological Malignancies will both hold simultaneous full-day conferences. The 3rd ESUI meeting will focus on innovations and new tools in urological imaging, while the EAU-ICUD Consensus meeting aims to conduct in-depth assessments of new treatments in systemic urological malignancies. As in previous years, EMUC anchors the scientific programme on in-depth discussions across disciplines while emphasising the role of translational and basic science and the need for cancer experts to implement forward-looking management strategies in their daily practice. From state-of-the-art sessions, best abstract presentations to panel discussions and debates, participants will have various opportunities to look closely into problem cases and examine second and third-line options for optimal care. Welcome to Lisbon! Prof. Joaquim Bellmunt, Boston (US) ESMO Chair Prof. Philip Poortmans, Nijmegen (NL) ESTRO President Prof. Per-Anders Abrahamsson, Malmö (SE) EAU Secretary General